Skip to main content
. 2017 Apr 8;23:1701–1706. doi: 10.12659/MSM.900233

Figure 2.

Figure 2

(A) The average body weight of groups. (B) Assessment of the depth of myometrial infiltration in groups. (C) Hotplate latency in untreated group (control) and tamoxifen-treated group. (D) Hotplate latency of multiple groups. UT – untreated; CT – control; LL – low-dose leonurine; HL – high-dose leonurine.